Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 8 shares of Common Stock at $565.2663 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 50,005.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 32 shares of Common Stock at $566.3359 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 49,973.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 135 shares of Common Stock at $567.7211 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 49,838.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 322 shares of Common Stock at $568.9849 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 49,516.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,674 shares of Common Stock at $570.017 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 46,842.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,432 shares of Common Stock at $570.8662 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 44,410.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 1,786 shares of Common Stock at $572.0569 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 42,624.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 1,654 shares of Common Stock at $572.893 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 40,970.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 457 shares of Common Stock at $573.8878 per share (Direct)
  Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Holds 0 shares of Common Stocl (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F14
• Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-04-29 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 91,288.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $573.65 to $574.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F12: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F13: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F14: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F2: This transaction was executed in multiple trades at prices ranging from $565.10 to $565.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $566.15 to $567.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $567.39 to $568.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $568.405 to $569.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $569.455 to $570.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $570.47 to $571.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $571.47 to $572.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $572.47 to $573.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.